SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Sandy Spring Bank

Sandy Spring Bank decreased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.2% in the fourth quarter, HoldingsChannel reports. The firm owned 32,906 shares of the exchange traded fund’s stock after selling 1,103 shares during the quarter. Sandy Spring Bank’s holdings in SPDR S&P Biotech ETF were worth $2,964,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently bought and sold shares of XBI. Golden State Wealth Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth approximately $29,000. Kohmann Bosshard Financial Services LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at $29,000. Avior Wealth Management LLC lifted its stake in shares of SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after purchasing an additional 307 shares during the last quarter. Bank of Jackson Hole Trust acquired a new position in SPDR S&P Biotech ETF during the 4th quarter worth about $43,000. Finally, Addison Advisors LLC lifted its stake in SPDR S&P Biotech ETF by 27.4% during the 4th quarter. Addison Advisors LLC now owns 535 shares of the exchange traded fund’s stock worth $48,000 after acquiring an additional 115 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 1.0 %

XBI opened at $86.59 on Friday. The firm has a market cap of $5.61 billion, a price-to-earnings ratio of 11.47 and a beta of 0.99. The stock’s 50-day moving average price is $89.64 and its 200 day moving average price is $94.48. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.